Robert S. Ward, NAE, Ph.D. (h) | President & Chief Executive Officer
Bob Ward, a well-known chemical engineer and expert in biomedical polymer science, is President and CEO of ExThera Medical and Chairman of Emergence Venture Partners LLC. Prior to joining ExThera, Ward was President and CEO of DSM Biomedical in Berkeley, California, a biomaterials and medical device company he founded in 1989, as The Polymer Technology Group (PTG). In 2010, Ward completed the sale of PTG to Royal DSM with a 132X investor return. Previously, Ward was Director of Research at Avco Medical Products and later spent a decade at Thoratec as President of the Biomaterials Division. He has numerous technical publications and patents and has received multiple awards and recognitions such as:
2018 – elected member of the National Academy of Engineering
2012 – awarded an honorary Ph.D. from the University of Massachusetts
2006 – received the Excellence in Surface Science award from The Surfaces in Biomaterials Foundation
2004 – named one of Medical Device & Diagnostic Industry’s 100 Most Notable People in the Medical Device Industry
2003 – awarded the Technology Innovation and Development Award from the Society for Biomaterials
Ward studied engineering management and polymer science at Northeastern University and received a bachelor’s degree in chemical engineering from the University of Massachusetts, Lowell.
Keith McCrea, Ph.D. | Vice President of Research & Development, & Chief Science Officer
Dr. Keith McCrea is Chief Science Officer and Vice President of Research and Development of ExThera Medical. He began his career at The Polymer Technology Group, where he built a state-of-the-art surface analysis laboratory focusing on a custom-built advanced laser technique that has aided in the identification and development of new intellectual property at the company. Dr. McCrea also led R&D projects to develop new materials for several different medical applications.
Dr. McCrea received his doctorate in physical chemistry, with an emphasis on surface modification and characterization from University of California, Berkeley. Dr. McCrea also serves on the scientific advisory board of NESAC/BIO, an NIH-sponsored program at the University of Washington with a mission to develop new techniques to solve biomedical related problems associated with surfaces and interfaces.
Vidur Sahney | Chief Operating Officer
Vidur Sahney joined ExThera Medical in May 2019 as Chief Operating Officer with more than 20 years of experience including operations, quality, validation, manufacturing, research and development and as an operations consultant for the medical device industry. Most recently Mr. Sahney served as Vice President of Operations at Sientra where he successfully led the initiative for FDA site clearance for a Class III / PMA device. Prior to that, Mr. Sahney was at Thoratec where he was responsible for commercializing the HeartMate Percutaneous Heart Pump (PHP) program, which later led to an acquisition by St. Jude Medical. Mr. Sahney has also served as Senior Director of Manufacturing and Operations at CR Bard Vascular, formerly Loma Vista Medical (by acquisition), where he worked to take a novel fiber composite balloon catheter used for TAVR from conception to commercialization while managing key contract manufacturer relationships. Mr. Sahney has worked as a Manufacturing Engineering Manager at Abbott Vascular and as a Senior Manufacturing Process Engineer at Abbott Diabetes Care.
Mr. Sahney received a Bachelor of Science in Mechanical Engineering from San Francisco State University.
Carla Kikken-Jussen | Managing Director, ExThera Medical Europe B.V.
With over thirty years ofEU medical device experience, Carla Kikken-Jussen oversees ExThera Medical’s European endeavors. Prior to joining the organization, Ms. Kikken-Jussen was the founder, President and CEO of Meditech Strategic Consultants where she was involved in various multi-center studies throughout Europe on relevant Ethics Committee submissions and Competent Authorities Notifications. Her background also includes extensive knowledge of EU Clinical Trials, EU Regulatory Submissions and CE Mark where she has conducted presentations on these topics at conferences across Europe and in the United States.
2013 – awarded The Next Women 100 Award, as one of the 100 Most Influential Business Women in the Netherlands
2010 – awarded The Federation Businesswomen Award 2010, as the best international, Female entrepreneur of 2010
Ms. Kikken-Jussen has her Bachelors Degree, Law University of Maastricht, Utrecht.
Scientific Advisory Board Members
Lakhmir S. Chawla, M.D.
Prior to joining the board, Dr. Chawla was a professor of medicine at the George Washington University Medical Center in Washington, D.C. where he directed research efforts for the Division of Critical Care Medicine. He previously headed the Division of Intensive Care Medicine at the Washington DC Veterans Affairs Medical Center, and currently serves as a clinical professor of medicine at the University of California, San Diego Medical Center. With a focus on critical care and nephrology, Dr. Chawla has led and supported several grants and research projects centered on acute kidney injury, renal disease, extracorporeal therapies, shock, and sepsis.
2013 – Alpha Omega Alpha, George Washington University
Dr. Chawla received a bachelor’s degree from Boston University, and a medical degree from The University of Medicine and Dentistry of New Jersey.
Herwig Gerlach, M.D., MBA, MSc, MAE
Professor Gerlach brings expertise in anesthesiology and critical care medicine as a board-certified physician and professor. A widely published researcher, he has investigated issues pertaining to intensive care, critical care and emergency medicine, post-operative care, and the treatment of sepsis, which are highly relevant to ExThera’s mission of developing new therapies for the treatment of bloodstream infections. In addition to his several roles throughout Germany, Prof. Dr. Gerlach also previously served as a research fellow at Columbia University in New York. He previously served as president of the German Sepsis Society and is now vice president.
1999 – Received the Annual Scientific Award, 19thInternational Symposium of Intensive Care and Emergency Medicine
1997 – Awarded a teaching certificate for Educational Presentations, European Respiratory Society
1993 – Received the Pulmedica Award, German Society for Research in Respiratory and Lung Diseases
Prof. Dr. Gerlach received a medical degree from Justus Liebig University, Giessen and a master of business administration degree in hospital management from Hochschule Neubrandenburg. He also received a master of science degree in clinical research and translational medicine from the University of Leipzig and a master of arts in education degree in applied ethics from The University of Münster.
Stuart L. Goldstein, M.D.
Dr. Goldstein contributes expertise in nephrology and brings to the board a unique perspective from his background in pediatric care. In addition to his current role at Cincinnati Children’s Hospital Medical Center, he holds a faculty position as a professor of pediatrics for the University of Cincinnati School of Medicine. Dr. Goldstein has also led and contributed research support for several research investigations focused on device therapies, including those with emphasis on renal failure and end-stage renal disease, for various institutions.
2018 – Received the Team Research Award for Learning Networks, Cincinnati Children’s Hospital Medical Center
2017 – Elected Fellow of the American Society of Nephrology
2016 – Awarded the Presidential Citation, Society for Critical Care Medicine
Dr. Goldstein received a bachelor’s degree from Pitzer College and a medical degree from Columbia University.